1 - 10 out of 13Page size: 10
  1. 2021

  2. Anti-GD2 based immunotherapy prevents late events in high-risk neuroblastoma patients over 18 months at diagnosis

    Tas, M. L., Dootjes, L. W., Fiocco, M., de Krijger, R. R., Dierselhuis, M. P., van Eijkelenburg, N. K. A., van Grotel, M., Kraal, K. C. J. M., Peek, A. M. L., Tytgat, G. A. M. & van Noesel, M. M., 1 Oct 2021, In: Cancers. 13, 19, 4941.

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Use of quality indicators in neuroblastoma treatment: A feasibility assessment

    Dijkstra, S., Kraal, K. C. J. M., Tytgat, G. A. M., van Noesel, M. M., Wijnen, M. H. W. A. & Hoogerbrugge, P. M., Sept 2021, In: Pediatric blood & cancer. 68, 9, e28301.

    Research output: Contribution to journal › Article › Academic › peer-review

  4. Immune monitoring during therapy reveals activitory and regulatory immune responses in high-risk neuroblastoma

    Szanto, C. L., Cornel, A. M., Tamminga, S. M., Delemarre, E. M., de Koning, C. C. H., van den Beemt, D. A. M. H., Dunnebach, E., Tas, M. L., Dierselhuis, M. P., Tytgat, L. G. A. M., van Noesel, M. M., Kraal, K. C. J. M., Boelens, J. J., Huitema, A. D. R. & Nierkens, S., 1 May 2021, In: Cancers. 13, 9, 2096.

    Research output: Contribution to journal › Article › Academic › peer-review

  5. Treatment-Related Toxicities During Anti-GD2 Immunotherapy in High-Risk Neuroblastoma Patients

    Blom, T., Lurvink, R., Aleven, L., Mensink, M., Wolfs, T., Dierselhuis, M., van Eijkelenburg, N., Kraal, K., van Noesel, M., van Grotel, M. & Tytgat, G., 17 Feb 2021, In: Frontiers in oncology. 10, 601076.

    Research output: Contribution to journal › Article › Academic › peer-review

  6. 2020

  7. Cisplatin and carboplatin pharmacokinetics in a pediatric patient with hepatoblastoma receiving peritoneal dialysis

    Nijstad, A. L., van Eijkelenburg, N. K. A., Kraal, K. C. J. M., Meijs, M. J. M., de Kanter, C. T. M. M., Lilien, M. R. & Huitema, A. D. R., 1 Sept 2020, In: Cancer chemotherapy and pharmacology. 86, 3, p. 445-449 5 p.

    Research output: Contribution to journal › Article › Academic › peer-review

  8. 2019

  9. Neuroblastoma stage 4S: Tumor regression rate and risk factors of progressive disease

    Tas, M. L., Nagtegaal, M., Kraal, K. C. J. M., Tytgat, G. A. M., Abeling, N. G. G. M., Pluijm, S. M. F., Zwaan, C. M., de Keizer, B., Molenaar, J. J. & van Noesel, M. M., 2019, In: Pediatric blood & cancer. e28061.

    Research output: Contribution to journal › Article › Academic › peer-review

  10. Peripheral stem cell apheresis is feasible post 131iodine-metaiodobenzylguanidine-therapy in high-risk neuroblastoma, but results in delayed platelet reconstitution

    Kraal, K. C. J. M., Timmerman, I., Kansen, H. M., van den Bos, C., Zsiros, J., van den Berg, H., Somers, S., Braakman, E., Peek, A. M. L., van Noesel, M. M., van der Schoot, C. E., Fiocco, M., Caron, H. N., Voermans, C. & Tytgat, G. A. M., 2019, In: Clinical cancer research. 25, 3, p. 1012-1021

    Research output: Contribution to journal › Article › Academic › peer-review

  11. 2017

  12. Feasibility, toxicity and response of upfront metaiodobenzylguanidine therapy therapy followed by German Pediatric Oncology Group Neuroblastoma 2004 protocol in newly diagnosed stage 4 neuroblastoma patients

    Kraal, K. C. J. M., Bleeker, G. M., van Eck-Smit, B. L. F., van Eijkelenburg, N. K. A., Berthold, F., van Noesel, M. M., Caron, H. N. & Tytgat, G. A. M., 2017, In: European journal of cancer (Oxford, England. 76, p. 188-196

    Research output: Contribution to journal › Article › Academic › peer-review

  13. Iodine-131-meta-iodobenzylguanidine therapy for patients with newly diagnosed high-risk neuroblastoma

    Kraal, K. C. J. M., van Dalen, E. C., Tytgat, G. A. M. & van Eck-Smit, B. L. F., 2017, In: Cochrane database of systematic reviews (Online). 2017, 4, p. CD010349

    Research output: Contribution to journal › Review article › Academic › peer-review

  14. Optimising therapy with 131I-MIBG for neuroblastoma patients and for neuroblastoma patients with intraspinal extension

    Kraal, K. C. J. M., 2017, 270 p.

    Research output: PhD Thesis › Phd-Thesis - Research and graduation internal

Previous 1 2 Next

ID: 110166